Tag: Innovaiva

July 22, 2017 Off

GSK submits EU filing for Relvar Ellipta extension

By Dino Mustafić

GlaxoSmithKline and Innoviva have asked the European Medicines Agency (EMA) to extend the use of  Relvar Ellipta, a once-daily fluticasone furoate/vilanterol-based (FF/VI) inhaled corticosteroid (ICS) / combination, in patients already adequately controlled on an ICS/LABA combination.